Stablepoint Partners’s CVS Health CVS Stock Holding History

Stablepoint Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.53M	Sell	76,180 -12,179	-14%	-$1.19M	0.88%	37
2026 Q2	$9.14M	Buy	88,359 +190	+0.2%	+$17K	1.26%	15
2026 Q1	$6.33M	Sell	88,169 -3,782	-4%	-$291K	0.94%	35
2025 Q4	$7.3M	Buy	91,951 +90	+0.1%	+$7.1K	1.14%	20
2025 Q3	$6.93M	Sell	91,861 -7,549	-8%	-$517K	1.1%	22
2025 Q2	$6.86M	Buy	99,410 +1,094	+1%	+$71.7K	1.17%	18
2025 Q1	$6.66M	Buy	98,316 +21,575	+28%	+$1.29M	1.21%	17
2024 Q4	$3.44M	Sell	76,741 -9,108	-11%	-$511K	0.63%	56
2024 Q3	$5.4M	Sell	85,849 -1,476	-2%	-$86.1K	0.98%	34
2024 Q2	$5.38M	Buy	87,325 +12,559	+17%	+$786K	1.04%	27
2024 Q1	$5.96M	Buy	74,766 +2,786	+4%	+$213K	1.21%	17
2023 Q4	$5.68M	Buy	+71,980	New	+$5.12M	1.46%	9

Other funds holding CVS

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Stablepoint Partners's CVS Position: Q3 2026 in Review

Stablepoint Partners reduced its CVS Health (CVS) stake by 14% in Q3 2026, selling an estimated $1.19M and leaving 76,180 shares worth $6.53M. The position accounts for 0.88% of the portfolio, ranked #37.

Stablepoint Partners first reported a position in CVS in Q4 2023 and has held it in 12 quarters since. The position peaked at $9.14M in Q2 2026. 1,324 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

Stablepoint Partners held 76,180 shares of CVS Health worth $6.53M as of Q3 2026.
Stablepoint Partners sold 12,179 CVS Health shares in Q3 2026, an estimated $1.19M.
CVS Health made up 0.88% of Stablepoint Partners's portfolio in Q3 2026, its #37 holding.
Stablepoint Partners first reported a position in CVS Health in Q4 2023 and has held it in 12 quarters since.
Stablepoint Partners's CVS Health position peaked at $9.14M in Q2 2026.
1,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Stablepoint Partners's 13F filing for Q3 2026, filed 3 Nov 2026.